← Back to screener

Aura Biosciences, Inc. AURA

Rank #2058 · Nasdaq · $0.6B market cap
⚠ Going-concern flag — the auditor (Ernst & Young LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
35.1
P/E
-7.3
P/B
2.81
ROE
-38.5%
Op. Margin
–%
Debt Ratio
14%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E -7.3x, P/B 2.81x. Ranks in the top 68% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -38.5%. Ranks in the top 86% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 14%. Ranks in the top 11% of the universe. Under 100% is generally considered a safe level.

Growth –
No data

Not enough historical filings to compute year-over-year growth yet.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2021–$-0.0B$-0.0B$-0.1B–-3
2022–$-0.0B$-0.0B$-0.1B–-7
2023–$-0.1B$-0.1B$0.2B–19
2024–$-0.1B$-0.1B$0.2B–15
2025–$-0.1B$-0.1B$0.2B–14

← See the full screener